![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Cytox Launches Genetic Test for Alzheimer’s Disease
Cytox Launches Genetic Test for Alzheimer’s Disease
Cytox has launched Variatech, a diagnostic test for Alzheimer’s Disease that relies on genetic biomarkers.
The blood-based test provides a comprehensive panel of AD informative SNPs to assist research and novel drug discovery studies.
Company studies indicate it has an accuracy rate over 80 percent. — Cynthia Jessup
Upcoming Events
-
21Oct